Novel silicones for transdermal therapeutic system, 5. A novel method of preparation of carboxy‐terminated polydimethylsiloxane and its enhancing effect on transdermal drug penetration
Novel silicones for transdermal therapeutic system, 5. A novel method of preparation of carboxy‐terminated polydimethylsiloxane and its enhancing effect on transdermal drug penetration
复制标题
DOI:
10.1002/marc.1992.030131001
复制
发表时间:
1992-10
期刊:
影响因子:
--
通讯作者:
Y. Nagase;T. Aoyagi;Tomoko Akimoko;T. Fuchikami
中科院分区:
文献类型:
--
作者:
Y. Nagase;T. Aoyagi;Tomoko Akimoko;T. Fuchikami
Recently, we reported on the preparations of functional poly (dimethylsi1oxane) s (PDMS) containing a quaternary salt moiety at one chain end, which acted as surfaceactive agents' x2). It was also found that those PDMS's could be used, especially, as practical transdermal penetration enhancers which were non-toxic to the skin owing to the bulkiness and the physiological inertness of the PDMS backbone. In the same context, the preparation of p-(ch1oromethyl) phenethyl-terminated PDMS (CMPPDMS) was investigated to synthesize PDMS containing a quaternary salt moiety at the chain end, as the terminal chloromethyl group could be easily quaternized upon reaction with pyridine derivatives or tertiary amines'). In this communication, another reaction of CMP-PDMS is conducted to obtain carboxy-terminated PDMS, which is expected to be a new type of transdermal penetration enhancer composed of a silicone moiety. We thought the carbonylation of the terminal chloromethyl group would be applicable in the presence of a transition metal catalyst, to afford p-(carboxymethy1) phenethyl-terminated PDMS. This sort of PDMS containing the carboxy group at one or at both chain ends has already been synthesized by Kazama et They prepared such a functional PDMS via living polymerization of hexamethylcyclotrisiloxane (D,) followed by deactivation with trimethylsilyl 4-(chlorodimethylsilyl) butanoate, of which the carboxy group was protected by the trimethylsilyl unit.